Summit Therapeutics Inc. (SMMT)
Summit Therapeutics Inc. Gross margin
| Jan'05 | Jan'06 | Jan'07 | Jan'08 | Jan'09 | Jan'10 | Jan'11 | Jan'12 | Jan'13 | Jan'14 | Jan'15 | Jan'16 | Jan'17 | Jan'18 | Jan'19 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 20.4% | 56.1% | 70.6% | 58.3% | 97.8% | 100.0% | 100.0% | 63.7% | 100.0% | 100.0% | 100.0% | 0.0% | 100.0% | 99.7% | 100.0% | 75.4% | 100.0% | 100.0% | (257.0%) | 0.0% |
Summit Therapeutics Inc. (SMMT) Gross margin comparison analysis
SMMT key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Summit Therapeutics Inc.'s Gross margin?
As of today, Microsoft Corp's last 12-month Gross margin is 386.0%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for Summit Therapeutics Inc. have been 41.1% over the past three years, and 55.5% over the past five years.
2) Is Summit Therapeutics Inc.'s Gross margin Good?
As of today, Summit Therapeutics Inc.'s Gross margin is 386.0%, which is higher than industry median of 65.7%. It indicates that Summit Therapeutics Inc.'s Gross margin is Good.